This document discusses salivary gland tumors. It begins with definitions of tumors and classifications of salivary glands and salivary gland tumors. It then covers the incidence, clinical features, histopathological features, and treatment plans for various benign and malignant salivary gland tumors. The document emphasizes that surgical resection is usually the primary treatment for salivary gland tumors, with adjuvant radiotherapy sometimes used as well.
Salivary gland tumours are a relatively rare and morphologically diverse group of lesions. So here are slides containing information about salivary gland tumours with images.
guideline for long case presentation,include history,examination,,investigation,treatment option,surgical procedure of superficial parotidectomy,short discussion about plemorphic adenoma
Childhood mumps, certain bacterial infections (for example, of the tonsils or teeth), and other diseases that are typically more common among adults (such as AIDS, Sjögren syndrome, diabetes mellitus, sarcoidosis, and bulimia) often cause swelling of the major salivary glands.
Salivary gland tumours are a relatively rare and morphologically diverse group of lesions. So here are slides containing information about salivary gland tumours with images.
guideline for long case presentation,include history,examination,,investigation,treatment option,surgical procedure of superficial parotidectomy,short discussion about plemorphic adenoma
Childhood mumps, certain bacterial infections (for example, of the tonsils or teeth), and other diseases that are typically more common among adults (such as AIDS, Sjögren syndrome, diabetes mellitus, sarcoidosis, and bulimia) often cause swelling of the major salivary glands.
Salivary gland tumors 12 (nx power lite) /certified fixed orthodontic courses...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
Salivary gland tumors 12 (nx power lite) /certified fixed orthodontic courses...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
Cutaneous manifestations of internal malignancy and paraneoplastic syndromes gamal sultan
cutaneous manifestations are extremely valuable marker because they may well be the presenting manifestation of an underlying neoplasm.
Increased clinician awareness could prove beneficial for the patient by promoting earlier screening and diagnosis, as well as increased intervention measures, thereby significantly affecting the chances of survival and/or improving the quality of life of the patient
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
4. OUTLINE
What is a tumor
Types of salivary glands
Classification of salivary gland tumors
Incidence
Clinical features
Histopathological features
Treatment plan for benign and malignant
tumors one by one.
Take home messege
5. Abnormal growth of tissue resulting from
uncontrolled, progressive multiplication of
cells, serving no physiological function.
Tumor can be benign or malignant..
6. 1. Major salivary gland
a. Parotid gland
b. Submandibular gland
c. Sublingual gland
2. Minor salivary gland
600 – 1,000 minor salivary gland distributed
throughout the mucosa of the upper
aerodigestive tract (more common in the soft
and hard palate).
7. Mainly classified into four groups
Adenomas
Carcinomas
Miscellaneous
Tumor-like lesions
13. Gland Frequency % Malignant %
Parotid 65 25
Submandibular 10 40
Sublingual <1 90
Minor Glands 25 50
Incidence
14. Pleomorphic adenoma is most common
benign tumor in all major and minor
salivary glands.
Most common malignancy in Parotid is
Mucoepidermoid CA while in
Submandibular It’s Adenoid Cystic CA.
15. Group Palate Lips Buccal and
Labial
Mucosa
Frequency % 42-54 21-25 11-15
Malignant % 30-58 Uper lip5-25
Lower lip 50-
90
30-58
Minor Salivary Glands
16. Upto 91% of retromolar tumors are
malignant.
Most tumors of floor of mouth and
tongue are malignant…
22. Several studies
implicate radiation as an
etiological factor
Dose-response pattern
Mostly parotid
Commonly
mucoepidermoid
carcinoma
23. The consistent association of EBV with
lymphoepithelial carcinoma of the salivary gland
suggest the virus probably plays causal role.
No evidence of a causal role of EBV in other
primary tumors of the salivary gland
24. Many genetic alternation may be responsible
for increased likelihood of developing salivary
gland neoplasm as
Allelic loss
Structural rearrangement
Monosomy & polysomy
25. Silica dust or wood dust
Using Kerosene as cooking fuel
Warthin’s tumor is strongly associated with
cigarette smoking
26.
27. Usually present as slowly growing painless swelling.
A sudden increase in size:
Infection
cystic degeneration
hemorrhage inside the mass
malignant transformation
MALIGNANT INDICATORS ARE:
Facial nerve paresis or paralysis.
Weakness or numbness of the tongue or in distribution of
branches of trigeminal nerve
Pain
Fixation
Cervical adenopathy
I)HISTORY CLINICAL EXAMINATION
28. V).INCISIONAL BIOPSY
C T & M R I give better understanding
Location & extent of the tumor
Its relation to major neurovascular structure
Perineural spread
Skull base invasion
Intracranial extension
II.ULTRASOUND OF THE TUMOR
IV.FINE NEEDLE ASPIRATION CYTOLOGY
III.RADIOLOGY
29.
30. Is derived from a mixture of ductal and
myoepithelial elements…
Painless, slow growing,
Peak age 30-60
Slight female predilection
In parotid gland most commonly
involves superficial lobe, 90%
In case of minor salivary gland palate is
most common site
31.
32. Well circumscribed, encapsulated
incomplete infilterations
Is composed of glandular
epithelium and
myoepithelial cells with a
mesenchyme like
background.
33. Best treated with surgical excision
SUPERFICIAL LOBE; Superficial
parotidectomy saving facial nerve.
DEEP LOBE; Total parotidectomy.
SUBMANDIBULAR; Total removal.
HARD PALATE; Excised down to
periosteum with mucosa.
95% cure rate.
5% malignant transformation.
34. Occurs almost exclusively in Parotid and
is second most common benign parotid
tumor.
1) Traditional hypothesis suggest that they
arise from heterotropic salivary gland
tissue found within parotid lymph nodes.
2) Proliferation of ductal epithelium that is
associated with 2ndry formation of
lymphoid tissue.
35. Slowly growing, painless, nodular mass
Firm or fluctuant
Tail of parotid
Unique feature is tendency to occur
bilaterally 5-7%
Peak prevalence is in 6th and 7th decade
36. Composed of a mixture of ductal epithelium
and lymphoid tissue . The epithelium is
oncocytic and cells are arranged in 2 layers.
Inner layer have papillary infoldings that
protrude into cystic spaces.
38. Surgical removal is treatment of choice.
6-12% recurrence
Malignant Warthin tumors have been
reported but are rare..
39. Is composed of large epithelial cells known as
oncocytes. ONCOCYTES have swollen
granular cytoplasm excessive
accumulation of mitochondria.
CLINICAL FEATURES:
Firm, slow growing, painless mass
8th decade
Slight female predilection
Occur primarily in major salivary glands
Rarely exceeds 4cm
41. MONOMORPHIC
ADENOMA
Canalicular adenoma Basal cell adenoma
Almost exclusively in
minor glands
Primarily tumor of parotid
Peak incidence 7th decade same
Female predilection Female predilection
Slowly growing painless
mass
Slowly growing painless
mass mostly < 3cm
42. CANALICULAR
ADENOMA
Single layered cords of
columnar and cuboidal
epithelial cells.
Large cystic spaces
often are created, with
epithelial papillary
projections.
Capsule often surrounds
but stellate islands
observed in 22-24%
cases.
46. Is most common salivary malignancy.
Is most common in parotid gland usually
appears as asymptomatic swelling.
Pain/ facial nerve palsy occurs with Hi grade
tumor.
In minor Palate Asymptomatic
blue/ red color, can be mistaken for mucocele.
Peak age 2-7th decade
Most common salivary malignancy in children
47. – Well-circumscribed to
partially encapsulated
to unencapsulated
– Solid tumor with cystic
spaces
48. 1. Mucous
2. Squamous
3. Intermediate cells
1. Relative numbers of mucous,
squamous and intermediate cells
2. Amount of cyst formation
3. Degree of cytologic atypia
49.
50. – Mucus = epidermoid
– Fewer and smaller
cysts
– Increasing
pleomorphism
and mitotic figures
51. – Epidermoid > mucus
– Solid islands of
squamous
and intermediate cells
- inc. pleomorphism
and mitotic activity
– Mistaken for SCCA
52. Influenced by location, Grade and stage of
tumor.
PAROTID; Early stage subtotal
parotidectomy, saving facial nerve
Advanced tumors total parotidectomy,
sacrificing facial nerve
SUBMANDIBULAR; total gland removal
In low grade lesions only modest margin of
normal tissue needs to be removed in Hi grade
wider resection is needed.
53. Neck disection is indicated for patients
with clinical evidence of metastatic
disease or Hi grade tumors.
Post-op radiation may also be used for
more aggressive tumors.
54. Slow growing mass
Pain is common and important finding
In parotid tumors facial nerve paralysis may
develop
Palatal tumors can be smooth surfaced or
ulcerated
Minor salivary gland 50-60%
Parotid 2-3%
Submandibular 12-17%
Middle aged adults
59. ACC is prone to local recurrence and
eventual distance metastasis.
is treatment of choice
may
improve survival in some cases.
Metastasis to regional lymph nodes is
uncommon, typically is
not indicated.
60. is poorest for tumors arising
in maxillary sinus and submandibular gland
and for tumors with solid histopathologic
patteren.
occurs in aprox.35% cases
most frequently to lungs and bones.
42%
61. Occurs almost exclusively in minor salivary
glands
65% cases occur in hard and soft palate
Older adults , more common in females
Slow growing, painless mass
Can erode or infilterate bone
62. – Isomorphic cells,
indistinct borders,
uniform nuclei
-Cells may grow in Solid,
cribriform,
ductular, tubular, trabecular,
cystic pattern
Perineural invasion is also
evidentt
63. Best treated with wide surgical excision
Metastasis to regional lymph nodes 10%
cases
Reported recurrence is 9-17%
64. Is a salivary gland malignancy with cells
that show serous acinar differentiation.
85% occur in parotid
9% occur in oral minor salivary glands
Occurs over a broad age range from 2nd-
7th decade
Females> males
65. Cells show features of serous acinar cells
and are fairly uniform in appearance,
showing different growth patterns
1. Solid
2. Microcystic
3. Papillary-cystic
4. follicular
66.
67. ; no clinical evidence of primary tumour
; 0.1 – 2.0 cms diameter without significant
local extension
; 2 – 4 cms without local extension
; 4– 6.0 cms without local extension
;
a) >6 cms without local extension
b) tumour of any size with significant extension
68. NX: Lymph nodes (LN) not evaluated
N0: no nodal invovment
N1: metastasis in only one LN ipsilateral
to the tumor with up to 3 cm
N2a: LN of 3 to 6 cm, ipsilateral
N2b: multiple ipsilateral LNs
N2c: bilateral or contralateral LN’s
N3: LN’s larger than 6 cm
70. STAGING
Stage I T1NoMo
Stage II T2NoMo
Stage III T3NoMo or
T1-3,N1Mo
Stage IVA T4aNo-1M0 or
T1-4aN2M0
Stage IVB T4bNxM0 or
TxN2-3M0
Stage IVC TxNxM1
71. If there is metastatic cervical L.A.P.
But there is controversy about
management of clinically negative neck
nodes
In high-grade or large tumor. The
incidence of occult regional disease is
relatively high, so the elective neck
dissection or selective (supraomohyoid)
neck disection should be considered
In low-grade malignancy the elective
neck disection not recommended
72. Microscopically positive margin
High grade including adenoid cystic
Involvement of skin, bone, nerve
LN spread
Large tumors requiring radical resection
Tumor spillage
Recurrence
73. Salivary gland tumors have diverse
pathology.
Principal treatment of salivary gland
tumors is surgical resection with safe
margins.
Used either as a single modality or in
conjuction with adjuvant radiotherapy.